Forschungszulage
Our team of experts will help you improve your business performance with the help of the research allowance.
Claim tax relief on your innovative projects, are you maximising your claims potential?
The significant financial investment required in order to launch a new biotechnology product can make the journey to viable launch and scale-up challenging. In order to encourage investment in biotech and maintain Germany’s position as a hub of innovation in this industry, the German government provides considerable tax relief for businesses who are innovating in this sector. Biotech companies are well positioned to be eligible for R&D Tax Credits as innovation is constantly being performed during the development process. This tax relief can help offset costs such as staff salaries or third party contracts.
Many companies in the sector are not aware that they carry out eligible R&D activities on a day-to-day basis within the meaning of the research allowance, for which they can claim a lucrative tax credit. The tax credit is offset against a company’s income tax liability and allows reinvestment in further R&D, for example.
Our Leyton experts assist companies in applying for the research grant. Our dedicated team consists of experienced engineers and scientists who provide our biotechnology clients with maximum economic benefits as well as significantly contribute to optimizing operating costs.
Our team of experts will help you improve your business performance with the help of the research allowance.
+
13
Countries
+
24
Years of business
+
26000
Clients
+
13
Countries
+
24
Years of business
+
26000
Clients